Borderline ovarian tumors: fifteen years' experience at a Scottish Tertiary Cancer Center

…, S Fegan, CW Martin, RL O'Donnell - International Journal of …, 2018 - ijgc.bmj.com
Objectives Since the recognition of borderline ovarian tumors (BOTs) in the 1970s, the
management of this subset of epithelial ovarian tumors has presented a challenge to clinicians. …

Hormone replacement therapy after treatment for a gynaecological malignancy

RL O'Donnell, KM Clement… - Current Opinion in …, 2016 - journals.lww.com
The risk and benefits of HRT should be evaluated for all women who undergo a premature
menopause as a result of gynaecological malignancy to reduce menopausal symptoms and …

Locally advanced vulva cancer: A single centre review of anovulvectomy and a systematic review of surgical, chemotherapy and radiotherapy alternatives. Is an …

RL O'Donnell, L Verleye, N Ratnavelu, K Galaal… - Gynecologic …, 2017 - Elsevier
Introduction Treatment of locally advanced vulva cancer (LAVC) remains challenging. Due
to the lack of randomised trials many questions regarding the indications for different …

BRAF wild-type, PTEN mutant malignant uveal melanoma arising within a mature ovarian teratoma: a case report and review of the literature

…, R Plummer, A Ralte, RL O'Donnell - International Journal …, 2020 - journals.lww.com
Mature cystic teratomas are common in women of all ages; however, malignant transformation
within them is rare and difficult to diagnosis preoperatively. Primary melanoma of the …

Post-operative pancreatic fistula following splenectomy with or without distal pancreatectomy at cytoreductive surgery in advanced ovarian cancer

…, P Korompelis, V Ghirardi, RL O'Donnell… - International Journal of …, 2020 - ijgc.bmj.com
Objective Splenectomy with or without distal pancreatectomy may be necessary at time of
cytoreductive surgery to achieve complete cytoreduction in advanced ovarian cancer. However…

Integration of computer-aided automated analysis algorithms in the development and validation of immunohistochemistry biomarkers in ovarian cancer

…, A Ralte, N Curtin, Y Drew, RL O'Donnell - Journal of Clinical …, 2021 - jcp.bmj.com
In an era when immunohistochemistry (IHC) is increasingly depended on for histological
subtyping, and IHC-determined biomarker informing rapid treatment choices is on the horizon; …

FARGO-360: a multi-disciplinary survey of practice and perspectives on provision of care for patients with frailty presenting with gynecological cancers in the UK and …

…, V McQueen, A Montgomery, RL O'Donnell… - International Journal of …, 2022 - ijgc.bmj.com
Objectives Frailty has been associated with worse cancer-related outcomes for people with
gynecological cancers. However, the lack of clear guidance on how to assess and modify …

Exploiting synthetic lethality in ovarian cancer

RL O'Donnell - 2016 - theses.ncl.ac.uk
The term ovarian cancer describes a set of distinct and heterogeneous diseases with an
overall poor prognosis. Standard treatment strategies are limited and new novel therapies …

Impact of surgical site infection (SSI) following gynaecological cancer surgery in the UK: a trainee-led multicentre audit and service evaluation

RL O'Donnell, G Angelopoulos, JP Beirne, I Biliatis… - BMJ open, 2019 - bmjopen.bmj.com
Objectives Surgical site infection (SSI) complicates 5% of all surgical procedures in the UK
and is a major cause of postoperative morbidity and a substantial drain on healthcare …

[HTML][HTML] The accuracy of diagnostic indicators for coeliac disease: A systematic review and meta-analysis

MMC Elwenspoek, J Jackson, R O'Donnell… - PLoS …, 2021 - journals.plos.org
Background The prevalence of coeliac disease (CD) is around 1%, but diagnosis is
challenged by varied presentation and non-specific symptoms and signs. This study aimed to …